P3 Health Partners Inc. (PIII)
NASDAQ: PIII · Real-Time Price · USD
8.89
0.00 (0.00%)
Apr 23, 2025, 4:00 PM EDT - Market closed
P3 Health Partners Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 |
| Revenue | 1,500 | 1,266 | 1,049 | 637.36 | 491.06 | Upgrade
|
| Revenue Growth (YoY) | 18.48% | 20.67% | 64.66% | 29.79% | 237.54% | Upgrade
|
| Cost of Revenue | 1,559 | 1,235 | 1,057 | 659.34 | 484.5 | Upgrade
|
| Gross Profit | -58.92 | 31.64 | -7.75 | -21.98 | 6.56 | Upgrade
|
| Selling, General & Admin | 120.13 | 125.6 | 162.38 | 119.41 | 54.89 | Upgrade
|
| Other Operating Expenses | 53.7 | -12.71 | -11.46 | 37.84 | -20.54 | Upgrade
|
| Operating Expenses | 259.88 | 199.57 | 238.21 | 165.97 | 35.15 | Upgrade
|
| Operating Income | -318.8 | -167.93 | -245.96 | -187.95 | -28.59 | Upgrade
|
| Interest Expense | -22.17 | -15.99 | -11.4 | -10.68 | -2.53 | Upgrade
|
| Other Non Operating Income (Expenses) | 23.57 | 0.18 | 12.62 | -5.72 | -0.29 | Upgrade
|
| EBT Excluding Unusual Items | -317.4 | -183.73 | -244.74 | -204.34 | -31.41 | Upgrade
|
| Impairment of Goodwill | - | - | -1,315 | - | - | Upgrade
|
| Gain (Loss) on Sale of Assets | 13.27 | - | - | - | - | Upgrade
|
| Asset Writedown | -8.06 | - | - | - | - | Upgrade
|
| Other Unusual Items | 6.2 | - | - | - | - | Upgrade
|
| Pretax Income | -305.99 | -183.73 | -1,560 | -204.34 | -31.41 | Upgrade
|
| Income Tax Expense | 4.39 | 2.7 | 1.86 | - | - | Upgrade
|
| Earnings From Continuing Operations | -310.38 | -186.43 | -1,562 | -204.34 | -31.41 | Upgrade
|
| Minority Interest in Earnings | 174.53 | 128.65 | 1,291 | 47.86 | - | Upgrade
|
| Net Income | -135.85 | -57.77 | -270.13 | -156.48 | -31.41 | Upgrade
|
| Preferred Dividends & Other Adjustments | - | - | - | -146.4 | - | Upgrade
|
| Net Income to Common | -135.85 | -57.77 | -270.13 | -10.08 | -31.41 | Upgrade
|
| Shares Outstanding (Basic) | 3 | 2 | 1 | 1 | 1 | Upgrade
|
| Shares Outstanding (Diluted) | 3 | 6 | 1 | 1 | 1 | Upgrade
|
| Shares Change (YoY) | -50.10% | 608.51% | - | -36.84% | 38.34% | Upgrade
|
| EPS (Basic) | -46.79 | -30.44 | -324.84 | -12.12 | -23.86 | Upgrade
|
| EPS (Diluted) | -54.06 | -31.64 | -325.00 | -12.12 | -23.86 | Upgrade
|
| Free Cash Flow | -110.13 | -77.86 | -128.25 | -69.88 | -27.52 | Upgrade
|
| Free Cash Flow Per Share | -37.46 | -13.21 | -154.23 | -84.03 | -20.90 | Upgrade
|
| Gross Margin | -3.93% | 2.50% | -0.74% | -3.45% | 1.34% | Upgrade
|
| Operating Margin | -21.25% | -13.26% | -23.44% | -29.49% | -5.82% | Upgrade
|
| Profit Margin | -9.05% | -4.56% | -25.74% | -1.58% | -6.40% | Upgrade
|
| Free Cash Flow Margin | -7.34% | -6.15% | -12.22% | -10.96% | -5.61% | Upgrade
|
| EBITDA | -232.74 | -81.26 | -158.67 | -179.22 | -27.79 | Upgrade
|
| EBITDA Margin | -15.51% | -6.42% | -15.12% | -28.12% | -5.66% | Upgrade
|
| D&A For EBITDA | 86.06 | 86.68 | 87.29 | 8.72 | 0.8 | Upgrade
|
| EBIT | -318.8 | -167.93 | -245.96 | -187.95 | -28.59 | Upgrade
|
| EBIT Margin | -21.25% | -13.26% | -23.44% | -29.49% | -5.82% | Upgrade
|
| Revenue as Reported | 1,500 | 1,266 | 1,049 | 637.36 | 491.06 | Upgrade
|
| Advertising Expenses | 1.3 | 3.2 | 4.5 | 2.1 | - | Upgrade
|
Updated Nov 12, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.